John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q3 2024)
According to the SEC 13F filed on Nov 13, 2024, the Ariel Appreciation Fund portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2024, the filing reported:
Increases - Allstate Corporation (The), Affiliated Managers Group, Inc., APA Corporation, Bio-Rad Laboratories, Inc., BorgWarner Inc., and 20 more
Reductions - ADT Inc., AFLAC Incorporated, Adtalem Global Education Inc., Axalta, Bank of America Corporation, and 73 more
Complete Exits - Evercore Inc., Patterson Companies, Inc., Stericycle, Inc., Truist Financial Corporation, U.S. Bancorp, and 4 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2024
|
ADT
ADT Inc.
|
Sell |
-1,244,311
|
|
Q3 2024
|
AFL
AFLAC Incorporated
|
Sell |
-155,572
|
|
Q3 2024
|
ALL
Allstate Corporation (The)
|
Buy |
+20,623
|
|
Q3 2024
|
AMG
Affiliated Managers Group, Inc.
|
Buy |
+9,344
|
|
Q3 2024
|
APA
APA Corporation
|
Buy |
+30,784
|
|
Q3 2024
|
ATGE
Adtalem Global Education Inc.
|
Sell |
-689,374
|
|
Q3 2024
|
AXTA
Axalta
|
Sell |
-72,876
|
|
Q3 2024
|
BAC
Bank of America Corporation
|
Sell |
-2,325
|
|
Q3 2024
|
BAP
Credicorp
|
Sell |
-104,512
|
|
Q3 2024
|
BCO
Brinks Company (The)
|
Sell |
-129,368
|
|
Q3 2024
|
BIDU
Baidu, Inc.
|
Sell |
-718,141
|
|
Q3 2024
|
BIO
Bio-Rad Laboratories, Inc.
|
Buy |
+274,508
|
|
Q3 2024
|
BMY
Bristol-Myers Squibb Company
|
Sell |
-276,697
|
|
Q3 2024
|
BOKF
BOK Financial Corporation
|
Sell |
-55,435
|
|
Q3 2024
|
BRC
Brady Corporation
|
Sell |
-275,390
|
|
Q3 2024
|
BWA
BorgWarner Inc.
|
Buy |
+138,024
|
|
Q3 2024
|
BYD
Boyd Gaming Corporation
|
Buy |
+153,446
|
|
Q3 2024
|
CBRE
CBRE Group Inc
|
Sell |
-69,487
|
|
Q3 2024
|
CG
The Carlyle Group Inc.
|
Buy |
+150,672
|
|
Q3 2024
|
CHKP
Check Point
|
Sell |
-136,577
|
|
Q3 2024
|
CLB
Core Laboratories Inc.
|
Sell |
-247,040
|
|
Q3 2024
|
CMA
Comerica Incorporated
|
Buy - Position Entry |
+304,481
|
|
Q3 2024
|
CNH
CNH Industrial
|
Sell |
-582,665
|
|
Q3 2024
|
COF
Capital One Financial Corporati
|
Sell |
-123,233
|
|
Q3 2024
|
CRL
Charles River Laboratories Inte
|
Sell |
-8,450
|
|
Q3 2024
|
CVS
CVS Health Corporation
|
Sell |
-52,277
|
|
Q3 2024
|
CVX
Chevron Corporation
|
Buy |
+6,226
|
|
Q3 2024
|
DHI
D.R. Horton, Inc.
|
Sell |
-24,998
|
|
Q3 2024
|
DNB
Dun & Bradstreet Holdings, Inc.
|
Sell |
-246,027
|
|
Q3 2024
|
DVA
DaVita Inc.
|
Sell |
-114,776
|
Page 1 of 4